Product Information

TRI-LINYAH TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1194 per EA under NDC 16714036301. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRI-LINYAH TABLET

Norgestimate and Ethinyl Estradiol
$0.1194per EA

Manufacturer

NorthStar Rx LLC

NDC

16714036301

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090524

FDA Approved

5/30/2012

TE Code

AB

On Market Since

5/30/2012

Price Statistics

The NADAC for TRI-LINYAH TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1194 per EA
All-time high$0.3811 (Apr 16, 2014)
All-time low$0.1072 (Jul 17, 2024)
52-week high$0.1332
52-week low$0.1194
Median price$0.1945
Average price$0.2165
Largest weekly change-19.9% (Jul 17, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-3.2%

1M

-5.5%

3M

-5.8%

6M

-10.1%

1Y

-9.2%

3Y

-12.1%

5Y

-35.4%

All

-65.4%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRI-LINYAH TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRI-LINYAH TABLET, manufactured by NorthStar Rx LLC, is $0.1194 per EA (NDC 16714036301), effective Nov 18, 2026.

How has the price of TRI-LINYAH TABLET changed over time?

Over the history we have for it, the NADAC for TRI-LINYAH TABLET has declined 65.4%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TRI-LINYAH TABLET?

Since Nov 28, 2013, the NADAC for TRI-LINYAH TABLET has ranged from a low of $0.1072 (Jul 17, 2024) to a high of $0.3811 (Apr 16, 2014), with a median of $0.1945 per EA.

Are there cheaper alternatives to TRI-LINYAH TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORG-ETHIN ESTRA 0.25-0.035 MG, is $0.1067 per EA — about 11% below TRI-LINYAH TABLET.

Who manufactures TRI-LINYAH TABLET?

TRI-LINYAH TABLET (NDC 16714036301) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.